Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for ...
Renowned dental innovator to join H2Ocean’s Academic Team on science translation, professional education strategy, and ...
Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in ...
That responsibility sits with Brett Roosendaal, commercial nutrition executive at Rainbow Chicken Farms and speaker at New ...
These questions form the basis of our conversation with Oleh Shamshur, Ambassador Extraordinary and Plenipotentiary of ...
9d
Merck: A Pharma Giant Trading At A Decade-Low Valuation While Executing Its Post-Keytruda Playbook
Merck (MRK) looks undervalued amid 2028 Keytruda patent fears—strong Q3 results, pipeline wins, and 12x P/E suggest upside.
From the way companies access senior expertise to how food is manufactured, wellness is consumed, skills are learned, and ...
Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics PortfolioHONG KONG, Jan. 5, 2026 /PRNewswire/ -- Sisram Medical ...
Mowi has entered into a strategic and industrial partnership agreement with Skretting/Nutreco where Mowi produces feed based ...
The strategic effort paid off: Within seven minutes of launch, POV Beauty pulled in $1 million in sales. Related: I’ve Helped ...
Ford and other carmakers must shift gears in their business plans away from EVs, a costly endeavor. Here is what it could ...
Instead of asking once a year, “What is our strategy?”, executive teams are asking, “What are we learning right now that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback